Buradasınız

Anasayfa » Content

Süperovulasyon Protokolünde Kullanılan GnRH Agonistinin Oosit Olgunluğu ve Çapına Etkileri

Morphological effect of different superovulation protocols to the mouse ovary

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Objectives: The objective of this study was to evaluate the effects of GnRHa on; ovarian morphology, oocyte diameter, number and maturation of oocytes in superovulated mice with FSH and hCG. Methods: Three month old BALB/C female mice (weight: 25-30 g) were assigned to 3 experimental groups, which were: control, superovulated and superovulated with GnRHa pretreatment (n=10 per group). Control mice had an i.p. injection of 0.1 ml 0.9% NaCl. Results: Superovulation induced with 5 IU FSH (i.p.) and 5 IU hCG (i.p.) 48 hours later. Mice in the superovulated with GnRHa pretreatment group received GnRHa (20 mg/kg) 24 hours before superovulation. Mice were sacrifice by cervical dislocation thirteen hours after hCG administration. The ovaries and oviducts harvested for histological assessment. Conclusion: The oocyte numbers and their maturation, ovulation rate, and the diameters of the oocytes were higher in GnRHa pretreated group than the control and superovulated ones (p<0.001). In conclusion, the GnRHa administration increased the number and the maturation of oocytes and the rate of ovulation in mice. Additionally, we concluded that as an oocyte assessment criteria evaluation of oocyte diameters in IVF procedure is an useful tool and better embryo for successful pregnancy.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-superovulasyon-protokolunde-kullanilan-gnrh-agonistinin-oosit-olgunlugu-capina-etkileri.pdf
  • 2
41-48
  • Turkish

REFERENCES

References: 

1. Guillemin R, Amoss M, Blackwell R, et al. Polypeptides
antagonists of the hypothalamic luteinizing hormone
releasing factor. Gynecol Invest 1971; 2: 2-12.
2. Schally AV, Nair RM, Redding TW, Arimura A. Isolation
of the luteinizing hormone and follicle-stimulating
hormone-releasing hormone from porcine hypothalami.
J Biol Chem 1971; 246: 7230-7236.
3. Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone-
receptor antagonists. Lancet 2001; 358: 1793-
1803.
4. Gründker C, Schulz K, Günthert AR, Emons G.
Luteinizing hormone-releasing hormone induces
nuclear factor kappaB-activation and inhibits apoptosis
in ovarian cancer cells. J Clin Endocrinol Metab
2000; 85: 3815-3820.
5. Fleming R, Adam AH, Barlow DH, et al. A new systematic
treatment for infertile women with abnormal
hormone profiles. Br J Obstet Gynaecol 1982; 89: 80-
3.
6. Porter RN, Smith W, Craft IL, et al. Induction of ovulation
for in-vitro fertilisation using buserelin and gonadotropins.
Lancet 1984; 2: 1284-1285.
7. Fleming R, Conaghan C, Coutts JR. The uses of LH-releasing
hormone and analogs in infertility. Ir J Med Sci
1986; 155(12 Suppl): 22-29.
8. Shaw RW, Ndukwe G, Imoedemhe DA, et al. Twin
pregnancy after pituitary desensitisation with LHRH
agonist and pure FSH. Lancet 1985; 2: 506-507.
9. Wildt L, Diedrich K, van der Ven H, et al. Ovarian
hyperstimulation for in-vitro fertilization controlled by
GnRH agonist administered in combination with human
menopausal gonadotrophins. Hum Reprod
1986; 1: 15-19.
10. Smitz J, Devroey P, Camus M, et al. The luteal phase
and early pregnancy after combined GnRH-agonist/
HMG treatment for superovulation in IVF or
GIFT. Hum Reprod 1988; 3: 585-590.
11. Fauser BC, Devroey P. Reproductive biology and IVF:
ovarian stimulation and luteal phase consequences.
Trends Endocrinol Metab 2003; 14: 236-242.
12. Fauser BC, Devroey P, Yen SS, et al. Minimal ovarian
stimulation for IVF: appraisal of potential benefits and
drawbacks. Hum Reprod 1999; 14: 2681-2686.
13. Oehninger S, Hodgen GD. Induction of ovulation for
assisted reproduction programmes. Baillieres Clin
Obstet Gynaecol 1990; 4: 541-573.
14. Trounson A, Mohr L. Human pregnancy following
cryopreservation, thawing and transfer of an eight-cell
embryo. Nature 1983; 305: 707-709.
15. Zeilmaker GH, Alberda AT, van Gent I, et al. Two
pregnancies following transfer of intact frozen-thawed
embryos. Fertil Steril 1984; 42: 293-296.
16. Wong WY, Richards JS. Induction of prostaglandin H
synthase in rat preovulatory follicles by gonadotropinreleasing
hormone. Endocrinology 1992; 130: 3512-
3521.
17. Yoshimura Y, Nakamura Y, Ando M, et al. Protein kinase
C mediates gonadotropin-releasing hormone
agonist-induced meiotic maturation of follicle-enclosed
rabbit oocytes. Biol Reprod 1992; 47: 118-125.
18. Yoshimura Y, Nakamura Y, Oda T, et al. Induction of
meiotic maturation of follicle-enclosed oocytes of
rabbits by a transient increase followed by an abrupt
decrease in cyclic AMP concentration. J Reprod Fertil
1992; 95: 803-812.
19. Lonergan P, Monaghan P, Rizos D, et al. Effect of follicle
size on bovine oocyte quality and developmental
competence following maturation, fertilization, and
culture in vitro. Mol Reprod Dev 1994; 37: 48-53.
20. Pavlok A, Lucas-Hahn A, Niemann H. Fertilization
and developmental competence of bovine oocytes
derived from different categories of antral follicles.
Mol Reprod Dev 1992; 31: 63-67.
21. Carolan C, Lonergan P, Monget P, et al. Effect of follicle
size and quality on the ability of follicular fluid
to support cytoplasmic maturation of bovine oocytes.
Mol Reprod Dev 1996; 43: 477-483.
22. Hazeleger NL, Hill DJ, Stubbing RB, Walton JS. Relationship
of morphology and follicular fluid environment
of bovine oocytes to their developmental potential
in vitro. Theriogenology 1995; 43: 509-522.
23. Suzuki H, Shibata H, Takita T, et al. Steroid contents
and cortical steroidogenic enzymes in non-hyperfunctioning
adrenal adenoma. Endocr J 1994; 41:
267-274.
24. Krisher RL. The effect of oocyte quality on development.
J Anim Sci 2004; 82: E14-23.

Thank you for copying data from http://www.arastirmax.com